DNB Carnegie Healthcare Seminar 2026
Logotype for Mentice

Mentice (MNTC) DNB Carnegie Healthcare Seminar 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Mentice

DNB Carnegie Healthcare Seminar 2026 summary

9 Mar, 2026

Market opportunity and industry trends

  • Solutions address global clinical challenges, especially in cardiovascular disease, with a focus on minimally invasive procedures and training for better patient outcomes.

  • Holds over 50% market share in image-guided therapy education, with 3x revenue growth over 8 years and revenues near SEK 280 million.

  • Operates globally with 8 locations and a customer base of over 1,000, serving nearly 3,500 installed systems.

  • Market opportunity in medical device industry is $75 million with double-digit growth; healthcare system segment is $500 million with single-digit growth but greater long-term potential.

  • Trends include a shift from open to minimally invasive surgery, driving demand for advanced simulation and training solutions.

Strategic direction and product development

  • Revenue split: 83% from medical device industry (MDI) and 17% from healthcare systems (HCS), with aspirations to grow HCS share.

  • Core products include VIST G7 VR simulators (90% of business), physiological flow models, and the FDA-cleared Ankyras decision support software.

  • Strategic focus on expanding from basic to advanced training, enabling clients to create custom cases and moving toward clinical use and digital twin solutions within 2–3 years.

  • Consolidated physical simulation business in Denver to streamline operations and support global distribution.

  • Ongoing R&D investments target digital twin technology and advanced simulation capabilities.

Financial performance and growth outlook

  • Q4 revenues reached SEK 91 million (18% organic growth), with net sales of SEK 279 million (3% organic growth) and order intake up 25%.

  • EBITDA margin improved to 25% in Q4, reflecting higher sales and cost measures.

  • Growth aspirations are 20–30% annually, with profitability targets of 20–30%.

  • Recent shareholder changes saw Gulf Offshore increase its stake, leading to board restructuring.

  • Q3 and Q4 showed strong business acceleration, with a robust project pipeline and broadening customer base.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more